期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 112, 期 4, 页码 473-476出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.10012SC
关键词
mexiletine; oxaliplatin; neuropathic pain
资金
- Ministry of Education, Culture, Sports, Science, and Technology of Japan [21590285]
- Grants-in-Aid for Scientific Research [21590285] Funding Source: KAKEN
Oxaliplatin is a platinum-based chemotherapy drug characterized by the development of acute and chronic peripheral neuropathies. Mexiletine, an orally available Na(+)-channel blocker, has widely been used in patients with chronic painful diabetic neuropathy. In the present study, we examined the effect of mexiletine on oxaliplatin-induced neuropathic pain in rats. Mexiletine (100, but not 10 and 30, mg/kg, p.o.) completely reversed both mechanical allodynia and cold hyperalgesia induced by oxaliplatin (4 mg/kg, i.p., twice a week). Lidocaine (30, but not 3 and 10, mg/kg, i.p.) also significantly relieved both pain behaviors. These results suggest that mexiletine may be effective in relieving the oxaliplatin-induced neuropathic pain clinically.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据